IQVIA Laboratories offers complete bioanalytical and ADME solutions for testing around the globe and across the product development spectrum. We combine knowledge from the collective services provided by our central labs, bioanalytical and ADME labs network, as well as integration into Quintiles global early clinical Phase I unit.
Presented at the 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, this poster details the IQVIA Laboratories team’s efforts to compare in vitro hepatocyte models (suspension, plated and Hμrel® co-culture) using the same lot of cryopreserved hepatocytes for calculating intrinsic clearance of low-turnover drugs.
Author:
Shelby Anderson, Ph.D.
Complete the form below to access this scientific poster
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)
Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
High Throughput ADME Testing
Minimizing turnaround time for ADME assays
Bioanalytical & ADME Laboratory Services
Accelerate and enhance your discovery, preclinical and clinical programs
ADME Services
Accelerating your drug discovery, preclinical and clinical programs with ADME services
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
Early Hit-to-Lead ADME Screening Bundle
Bundled Screening Assays to Accelerate Candidate Selection in Drug Discovery
